|
|
Gene Symbol |
CRH |
|
Aliases |
CRF, CRH1 |
|
Entrez Gene ID |
|
|
Gene Name |
Corticotropin releasing hormone |
|
Chromosomal Location |
8q13.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a member of the corticotropin-releasing factor family. The encoded preproprotein is proteolytically processed to generate the mature neuropeptide hormone. In response to stress, this hormone is secreted by the paraventricular nucleus (PVN) of the hypothalamus, binds to corticotropin releasing hormone receptors and stimulates the release of adrenocorticotropic hormone from the pituitary gland. Marked reduction in this protein has been observed in association with Alzheimer's disease. Autosomal recessive hypothalamic corticotropin deficiency has multiple and potentially fatal metabolic consequences including hypoglycemia and hepatitis. In addition to production in the hypothalamus, this protein is also synthesized in peripheral tissues, such as T lymphocytes, and is highly expressed in the placenta. In the placenta it is a marker that determines the length of gestation and the timing of parturition and delivery. A rapid increase in circulating levels of the hormone occurs at the onset of parturition, suggesting that, in addition to its metabolic functions, this protein may act as a trigger for parturition. [provided by RefSeq, Nov 2015]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Corticoliberin, corticotropin-releasing factor |
|
Function |
Hormone regulating the release of corticotropin from pituitary gland (By similarity). Induces NLRP6 in intestinal epithelial cells, hence may influence gut microbiota profile (By similarity). |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000369050 |
|
P04798 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Atonic seizures |
|
Pituitary apoplexy |
|
Endocrine System Diseases |
Cushing Syndrome |
|
PCOS |
|
Eye Diseases |
Neuroretinitis |
|
Retinitis |
|
Nervous System Diseases |
Seizures |
|
Jacksonian Seizure |
|
Epilepsy |
|
Status Epilepticus |
|
Infantile Spasm |
|
Status marmoratus |
|
Petit mal status |
|
Spasmus nutans |
|
Movement Disorders |
|
Psychiatric/Brain disorders |
Anxiety Disorders |
17293045, 12438692, 14575894, 8736133, 12424556, 7816204, 21268831, 11440811, 11875628, 22231481, 16495007 |
Mental Depression |
18698320, 12438692, 20692103, 23529111, 22378896, 19846118, 22475622, 23768074, 25422958, 24630468, 25578258, 23726670, 20029939 |
Alzheimer Disease |
|
Psychomotor Disorders |
|
Mood Disorders |
|
Melancholia |
|
Cognition Disorders |
|
Bipolar Disorder |
|
Anhedonia |
|
Dysthymic Disorder |
|
Senile Dementia |
|
Schizophrenia |
|
Skin and Connective Tissue Diseases |
Alopecia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
ACTH |
|
|
|
Related
|
|
This study supports the hypothesis that the adrenal gland in patients with PCO produces increased amounts of androstenedione in response to ACTH stimulation. |
|
ACTH |
|
|
|
Related
|
12 women aged 17 to 32 years having PCOS and 15control |
The results are consistent with the hypothesis that women with PCOS may demonstrate hyperfunction of the hypothalamic-pituitary-adrenal axis, which may be involved in the physiopathologic events leading to the complexity of the syndrome. |
|
|
|
|